After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Cidara Therapeutics Inc is $1.13B. A total of 1.25 million shares were traded on the day, compared to an average of 553.22K shares.
In the most recent transaction, RA CAPITAL MANAGEMENT, L.P. bought 2,272,727 shares of CDTX for 44.00 per share on Jun 26 ’25. After the transaction, the Director now owns 3,365,523 company shares. In a previous transaction on Jun 02 ’25, Mineo Chrysa bought 2,270 shares at 21.71 per share. CDTX shares that Director owns now total 2,270.
Among the insiders who bought shares, Mineo Chrysa acquired of 1,050 shares on Jun 03 ’25 at a per-share price of $23.44. This resulted in the Director holding 3,320 shares of CDTX after the transaction. In another insider transaction, Ward Shane sold 1,664 shares at $21.96 per share on Mar 11 ’25. Company shares held by the COO & CLO now total 14,674.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, CDTX has a high of $56.83 and a low of $10.14.
As of this writing, CDTX has an earnings estimate of -$1.84 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$1.19 per share and a lower estimate of -$2.34.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CDTX’s latest balance sheet shows that the firm has $59.68M in Cash & Short Term Investments as of fiscal 2021. There were $5.06M in debt and $34.02M in liabilities at the time. Its Book Value Per Share was $11.60, while its Total Shareholder’s Equity was $21.57M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDTX is Buy with a score of 4.71.
